Cosciens Biopharma Inc (CSCI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,766 | 1,483 | 2,749 | 1,500 | 3,322 |
| Cost of Goods | 1,157 | 862 | 1,775 | 1,057 | 1,273 |
| Gross Profit | 609 | 621 | 974 | 443 | 2,049 |
| Operating Expenses | 2,997 | 2,628 | 3,327 | 4,060 | 5,659 |
| Operating Income | -2,388 | -2,007 | -2,353 | -3,617 | -3,610 |
| Interest Expense | 32 | 43 | 23 | 70 | 23 |
| Other Income | 247 | 231 | -324 | 32 | -2,016 |
| Pre-tax Income | -2,173 | -1,819 | -2,700 | -3,655 | -5,649 |
| Income Tax | 10 | 0 | 1 | 0 | 1,082 |
| Net Income Continuous | -2,183 | -1,819 | -2,701 | -3,655 | -6,731 |
| Net Income | $-2,183 | $-1,819 | $-2,701 | $-3,655 | $-6,731 |
| EPS Basic Total Ops | -0.68 | -0.57 | -0.85 | -1.16 | -2.35 |
| EPS Basic Continuous Ops | -0.68 | -0.57 | -0.85 | -1.16 | -2.35 |
| EPS Diluted Total Ops | -0.68 | -0.57 | -0.85 | -1.16 | -2.35 |
| EPS Diluted Continuous Ops | -0.68 | -0.57 | -0.85 | -1.16 | -2.35 |
| EBITDA(a) | $-1,852 | $-1,489 | $-2,390 | $-3,260 | $-5,234 |